70
Participants
Start Date
December 18, 2023
Primary Completion Date
November 30, 2027
Study Completion Date
November 30, 2027
RO7507062
RO7507062 solution for injection will be administered SC as specified in each treatment part (arm).
Tocilizumab
When applicable, tocilizumab solution for infusion will be administered intravenously at 8 milligram per kilogram (mg/kg) for participants \>/= 30 kg or at 12 mg/kg for participants \< 30 kg.
RECRUITING
Chang Gung Medical Foundation - Linkou, Taoyuan District
ACTIVE_NOT_RECRUITING
Centre For Human Drug Research, Leiden
RECRUITING
Hospital General De Mexico, México
RECRUITING
FARMOVS (Pty) Ltd, Bloemfontein
RECRUITING
Charité Research Organisation GmbH, Berlin
RECRUITING
Ramathibodi Hospital, Mahidol Uni, Bangkok
RECRUITING
Hospital Universitario Reina Sofia, Córdoba
RECRUITING
Clínica San Juan Bautista CSJB, Lima
RECRUITING
Hospital General Universitario Gregorio Marañon, Madrid
RECRUITING
Hospital Universitario 12 de Octubre, Madrid
RECRUITING
Hôpital Saint Eloi, Montpellier
RECRUITING
Chung Shan Medical University Hospital, Taichung
RECRUITING
Universitätsklinikum Duesseldorf, Düsseldorf
RECRUITING
CREA Hospital Mexico Americano, Guadalajara
RECRUITING
Groupe Hospitalier Pitie-Salpetriere, Paris
RECRUITING
Hospital Umum Sarawak, Kuching
RECRUITING
Oncomedica S.A., Montería
RECRUITING
Clinica De La Costa, Barranquilla
RECRUITING
Hospital Pablo Tobon Uribe, Medellín
RECRUITING
Hospital Angeles De Lindavista, Mexico City
RECRUITING
Uniwersytecki Szpital Kliniczny w Poznaniu, Późna
RECRUITING
MICS Centrum Medyczne Damiana, Walbrzyska, Warsaw
RECRUITING
Wojskowy Instytut Medyczny- Panstwowy Instytut Badawczy, Warsaw
RECRUITING
UCL Hospital NHS Trust, London
Hoffmann-La Roche
INDUSTRY